213 related articles for article (PubMed ID: 32294764)
1. Targeted Treatments for Inherited Neuromuscular Diseases of Childhood.
Fay AJ; Knox R; Neil EE; Strober J
Semin Neurol; 2020 Jun; 40(3):335-341. PubMed ID: 32294764
[TBL] [Abstract][Full Text] [Related]
2. New pharmacotherapies for genetic neuromuscular disorders: opportunities and challenges.
Ricci F; Vacchetti M; Brusa C; Vercelli L; Davico C; Vitiello B; Mongini T
Expert Rev Clin Pharmacol; 2019 Aug; 12(8):757-770. PubMed ID: 31220956
[No Abstract] [Full Text] [Related]
3. Current Genetic Survey and Potential Gene-Targeting Therapeutics for Neuromuscular Diseases.
Chiu W; Hsun YH; Chang KJ; Yarmishyn AA; Hsiao YJ; Chien Y; Chien CS; Ma C; Yang YP; Tsai PH; Chiou SH; Lin TY; Cheng HM
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33339321
[TBL] [Abstract][Full Text] [Related]
4. [Innovative therapeutic approaches for hereditary neuromuscular diseases].
Kirschner J; Schoser B
Nervenarzt; 2018 Oct; 89(10):1115-1122. PubMed ID: 30171303
[TBL] [Abstract][Full Text] [Related]
5. Antisense Oligonucleotide-Based Therapy for Neuromuscular Disease.
Sardone V; Zhou H; Muntoni F; Ferlini A; Falzarano MS
Molecules; 2017 Apr; 22(4):. PubMed ID: 28379182
[TBL] [Abstract][Full Text] [Related]
6. Genetic therapies for inherited neuromuscular disorders.
Scoto M; Finkel R; Mercuri E; Muntoni F
Lancet Child Adolesc Health; 2018 Aug; 2(8):600-609. PubMed ID: 30119719
[TBL] [Abstract][Full Text] [Related]
7. Postnatal gene therapy for neuromuscular diseases - opportunities and limitations.
Kirschner J
J Perinat Med; 2021 Oct; 49(8):1011-1015. PubMed ID: 34499826
[TBL] [Abstract][Full Text] [Related]
8. Gene and splicing therapies for neuromuscular diseases.
Benchaouir R; Robin V; Goyenvalle A
Front Biosci (Landmark Ed); 2015 Jun; 20(8):1190-233. PubMed ID: 25961553
[TBL] [Abstract][Full Text] [Related]
9. Genetic approaches to the treatment of inherited neuromuscular diseases.
Ravi B; Antonellis A; Sumner CJ; Lieberman AP
Hum Mol Genet; 2019 Oct; 28(R1):R55-R64. PubMed ID: 31227836
[TBL] [Abstract][Full Text] [Related]
10. Gene-based therapies for neuromuscular disorders.
Zanoteli E; França MC; Marques W
Arq Neuropsiquiatr; 2024 Jun; 82(6):1-10. PubMed ID: 38325390
[TBL] [Abstract][Full Text] [Related]
11. Genome engineering: a new approach to gene therapy for neuromuscular disorders.
Nelson CE; Robinson-Hamm JN; Gersbach CA
Nat Rev Neurol; 2017 Nov; 13(11):647-661. PubMed ID: 28960187
[TBL] [Abstract][Full Text] [Related]
12. Genetic neuromuscular disorders: living the era of a therapeutic revolution. Part 2: diseases of motor neuron and skeletal muscle.
Vita G; Vita GL; Musumeci O; Rodolico C; Messina S
Neurol Sci; 2019 Apr; 40(4):671-681. PubMed ID: 30805745
[TBL] [Abstract][Full Text] [Related]
13. Gene therapeutic strategies and relevant clinical trials in neuromuscular disorder in China.
Hu C; Li X
Gene Ther; 2020 Aug; 27(7-8):321-328. PubMed ID: 32591735
[TBL] [Abstract][Full Text] [Related]
14. [Neuromuscular diseases (NME). I. Spinal muscular atrophy, peripheral nerve diseases, congenital myasthenia gravis].
Schara U; Mortier W
Nervenarzt; 2004 Dec; 75(12):1231-45; quiz 1246-7. PubMed ID: 15756726
[TBL] [Abstract][Full Text] [Related]
15. [Gene therapies for neuromuscular diseases].
Saffari A; Weiler M; Hoffmann GF; Ziegler A
Nervenarzt; 2019 Aug; 90(8):809-816. PubMed ID: 31286145
[TBL] [Abstract][Full Text] [Related]
16. An update on RNA-targeting therapies for neuromuscular disorders.
Jirka S; Aartsma-Rus A
Curr Opin Neurol; 2015 Oct; 28(5):515-21. PubMed ID: 26280937
[TBL] [Abstract][Full Text] [Related]
17. Special Issue "Genetic Advances in Neuromuscular Disorders: From Gene Identification to Gene Therapy".
Arechavala-Gomeza V; Gonzalez-Quereda L
Genes (Basel); 2021 Feb; 12(2):. PubMed ID: 33567614
[TBL] [Abstract][Full Text] [Related]
18. [Development of therapies against neuromuscular diseases causing muscle atrophy].
Tsuchida K
Nihon Shinkei Seishin Yakurigaku Zasshi; 2006 Nov; 26(5-6):229-33. PubMed ID: 17240849
[TBL] [Abstract][Full Text] [Related]
19. RNA Targeting in Inherited Neuromuscular Disorders: Novel Therapeutic Strategies to Counteract Mis-Splicing.
Verdile V; Guizzo G; Ferrante G; Paronetto MP
Cells; 2021 Oct; 10(11):. PubMed ID: 34831073
[TBL] [Abstract][Full Text] [Related]
20. [Molecular therapies in childhood neuromuscular disorders-definite hope versus unknown pitfalls].
Blaschek A; Vill K; Müller-Felber W; Schara U
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2020 Jul; 63(7):891-897. PubMed ID: 32542436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
